Delivery Order SPE2DB22D2007-SPE2DB24FJ5DR

Award Date 8/16/24
Potential Completion Date 9/9/24
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,683.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the pharmaceutical product NUBEQA 300 MG TABLET 120S, with a completion date of November 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by the DLA and other agencies to supply a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,683.97 firm fixed-price delivery order is for the supply of NUBEQA 300 MG tablets, a prescription medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a delivery order contract valued at $3,518.40 for the supply of NUBEQA 300 MG TABLET 120S. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,691.72 firm fixed-price delivery order is for the supply of NUBEQA 300 MG tablets, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing...
This federal contract award, with ID SPE2DX15D3005|SPE2DX24F3UKN, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $4,683.97 firm fixed-price delivery order is for the supply of 120 tablets of the pharmaceutical product NUBEQA 300 MG. The contract has an ultimate completion date of October 4, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by various...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,845.85 firm fixed-price delivery order is for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award, with an ID of SPE2DB20D3103 and SPE2DB24FP5U9, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The $14,051.91 firm fixed-price delivery order is for the supply of 4565179103 NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of August 7, 2024 and was awarded on July 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these medical supplies to support military...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the prescription drug NUBEQA 300 MG TABLET 120S to federal government agencies. The contract, valued at $4,683.97, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of December 10, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,691.72 firm fixed-price delivery order is for the supply of 120 count tablets of the pharmaceutical product NUBEQA 300 MG. The contract has a completion date of December 11, 2024 and was awarded on November 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,641.98, is a Firm Fixed Price Delivery Order for the supply of NUBEQA 300 MG TABLET 120S. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ5DR
    Delivery Order

This federal contract award, with ID SPE2DB22D2007|SPE2DB24FJ5DR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The $4,683.97 firm fixed price delivery order is for the supply of NUBEQA 300 MG TABLET 120S, a prescription pharmaceutical product. This award is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of medical commodities, including specialty medications, generic drugs, and medical supplies, to support military treatment facilities, veteran's hospitals, and other government healthcare programs. Notable Indefinite Delivery Contracts (IDCs) held by Amerisourcebergen include a $999,999,999 IDC with DLA Troop Support Medical through December 2025, and a $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, for delivering essential pharmaceutical and medical products.

Generated 11/15/24, 9:24 AM